Please use this identifier to cite or link to this item:
https://doi.org/10.3978/j.issn.1000-9604.2013.11.12
Title: | Recombinant adenovirus-p53 (Gendicine) sensitizes a pancreatic carcinoma cell line to radiation | Authors: | Li, J. Pan, J. Zhu, X. Su, Y. Bao, L. Qiu, S. Zou, C. Cai, Y. Wu, J. Tham, I.W.K. |
Keywords: | Pancreatic carcinoma Radiosensitization Recombinant adenovirus-p53 (rad-p53) Transfection |
Issue Date: | 2013 | Citation: | Li, J., Pan, J., Zhu, X., Su, Y., Bao, L., Qiu, S., Zou, C., Cai, Y., Wu, J., Tham, I.W.K. (2013). Recombinant adenovirus-p53 (Gendicine) sensitizes a pancreatic carcinoma cell line to radiation. Chinese Journal of Cancer Research 25 (6) : 715-721. ScholarBank@NUS Repository. https://doi.org/10.3978/j.issn.1000-9604.2013.11.12 | Abstract: | Objective: In this study, we examine the effects of recombinant adenovirus-p53 (rAd-p53) on the pancreatic carcinoma cell line SW1990. Specifically, we determine if expression of rAd-p53 sensitizes these cells to radiation. Methods: Following transfection of SW1990 cells with rAd-p53, we measured expression of P53, P21 and Bax by immunocytochemistry. Both transfected and control cell lines were irradiated with a range of doses, and the survival fractions (SF) were calculated. Dose survival curves were constructed and modeled for comparison. Results: Transfection of SW1990 cells with rAd-p53 resulted in increased expression of P53, P21 and Bax in a time-dependent manner. At 96 h after transfection, 89.92% of cells expressed P53, 56.8% expressed P21, and 76.50% expressed Bax. The SF following radiation was lower in the rAd-p53 transfected cells compared to the control cells, suggesting that rAd-p53 sensitizes SW1990 cells to radiation (D0 for the experimental and control groups was 2.199 and 2.462, respectively). Conclusions: Use of the adenoviral vector is an effective means of transfecting SW1990 cells with wild-type P53, and this sensitizes the cell line to irradiation. This work suggests that combining rAd-p53 with radiation therapy in pancreatic cancer may be therapeutically beneficial. © Chinese Journal of Cancer Research. All rights reserved. | Source Title: | Chinese Journal of Cancer Research | URI: | http://scholarbank.nus.edu.sg/handle/10635/125445 | ISSN: | 19930631 | DOI: | 10.3978/j.issn.1000-9604.2013.11.12 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.